Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Clinical trial NCT04246801 · COMPLETED
Trial details
- NCT number
- NCT04246801
- Sponsor
- Salvat
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-10
- Primary completion
- 2021-05-19
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.